Abstract

PROBLEM TO BE SOLVED: To obtain a medicinal agent, comprising a functional material and a decomposable gel, enabling control of a release rate of a functional material and long-term sustained release, in which the gel itself decomposes or disappears after finishing release of the functional material. SOLUTION: This medicinal agent comprises the decomposable gel having ≤98 wt.% saturated water content and the functional material. In the medicinal agent, preferably, release rate of the functional material is controlled by controlling the saturated water content of the decomposable gel. COPYRIGHT: (C)2005,JPO&NCIPI
【課題】機能性材料を含有する分解性ゲルであって、機能性材料の放出速度の制御及び長期に亘る徐放が可能で、且つ機能性材料放出終了後には該ゲル自体が分解消滅する、薬剤を提供すること。 【解決手段】飽和含水率が98重量%以下である分解性ゲルと、機能性材料とを含有する薬剤による。 【選択図】なし

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (6)

    Publication numberPublication dateAssigneeTitle
    JP-2001511773-AAugust 14, 2001フェムファーマ薬学的調製物およびそれらの領域的投与のための方法
    JP-2002145797-AMay 22, 2002Kaken Pharmaceut Co Ltd, Yasuhiko Tabata, Seishi Yoneda, 泰彦 田畑, 科研製薬株式会社, 正始 米田Material comprising hydrogel and used for cell transplantation therapy
    JP-H01221318-ASeptember 04, 1989Masao Igarashi, Tokyo Tanabe Co LtdDanazol-containing pharmaceutical for local administration
    JP-H0390029-AApril 16, 1991Tokyo Tanabe Co LtdDanazol suppository
    JP-H05229934-ASeptember 07, 1993Res Dev Corp Of Japan, 新技術事業団不均質構造薬物放出デバイス
    JP-H07102002-AApril 18, 1995Gunze Ltd, Kaken Pharmaceut Co Ltd, グンゼ株式会社, 科研製薬株式会社Cross-linked hyaluronic acid and compound material thereof

NO-Patent Citations (0)

    Title

Cited By (1)

    Publication numberPublication dateAssigneeTitle
    JP-2011505369-AFebruary 24, 2011アラーガン、インコーポレイテッドAllergan,Incorporated薬剤の持続送達のための多糖ゲル組成物および方法